Shareholders: EpiPen maker's $98M payout is too much

Mylan just got a rare scolding from shareholders fuming over a $98 million pay package for its former CEO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.